Leap Therapeutics Inc (LPTX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Leap Therapeutics Inc (LPTX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010992
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Leap Therapeutics Inc (Leap Therapeutics) is a clinical-stage biopharmaceutical company that acquires, develops novel therapeutics for cancer research. The company’s pipeline encompasses DKN-01, a humanized monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, and in clinical trials for the treatment of in esophageal cancer, cholangiocarcinoma, a form of bile duct cancer; and non-small cell lung cancer. Its TRX518, is a humanized anti-GITR (glucocorticoid-induced tumor necrosis factor receptor) monoclonal antibody that enhances the immune system’s anti-tumor response and is in Phase 1 clinical trials for the treatment of solid tumors. Leap Therapeutics is headquartered in Cambridge, Massachusetts, the US.

Leap Therapeutics Inc (LPTX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Leap Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Leap Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Leap Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Leap Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Leap Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Leap Therapeutics Inc, Medical Equipment, Deal Details 10
Merger 10
GITR Merges with HealthCare Pharmaceuticals to Form Leap Therapeutics 10
Equity Offering 11
Leap Therapeutics Plans to Raise Funds in Secondary Offering of Shares 11
Leap Therapeutics to Raise USD18 Million in Private Placement of Units 12
Acquisition 14
Leap Therapeutics Acquires Macrocure 14
Leap Therapeutics Inc – Key Competitors 16
Leap Therapeutics Inc – Key Employees 17
Leap Therapeutics Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Leap Therapeutics Inc, Medical Equipment, Key Facts, 2015 2
Leap Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Leap Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Leap Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Leap Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Leap Therapeutics Inc, Deals By Market, 2011 to YTD 2017 8
Leap Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
GITR Merges with HealthCare Pharmaceuticals to Form Leap Therapeutics 10
Leap Therapeutics Plans to Raise Funds in Secondary Offering of Shares 11
Leap Therapeutics to Raise USD18 Million in Private Placement of Units 12
Leap Therapeutics Acquires Macrocure 14
Leap Therapeutics Inc, Key Competitors 16
Leap Therapeutics Inc, Key Employees 17
Leap Therapeutics Inc, Subsidiaries 18

★海外企業調査レポート[Leap Therapeutics Inc (LPTX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Evonik Industries AG:企業の戦略・SWOT・財務分析
    SummaryEvonik Industries AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fi …
  • EOG Resources, Inc.:企業の戦略・SWOT・財務情報
    EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Steatite Limited:企業の戦略・SWOT・財務分析
    SummarySteatite Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findin …
  • SandRidge Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    SandRidge Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary SandRidge Energy Inc (SandRidge) is an upstream energy company. It develops, explores for, and produces oil and natural gas in the Mid-Continent and Rockies regions of the US. In Mid-Continent, …
  • Zogenix Inc (ZGNX):企業のM&A・提携動向(医療機器分野)
    Summary Zogenix Inc (Zogenix) is a pharmaceutical company that develops and commercializes injectable therapies and delivery systems for treating central nervous system disorders and pain. The company’s product portfolio includes Zohydro ER, Sumavel DosePro and undisclosed dosepro CNS product candid …
  • National Fertilizers Limited (NFL):企業概要、財務及び戦略的SWOT分析
    Summary National Fertilizers Limited (NFL) is a fertilizers manufacturer. The company’s products include Kisan urea, Neem coated urea, bio-fertilizers, industrial products and traded products. It offers bio-fertilizer such as nitrogenbio-fertilizer and phosphorous bio-fertilizer. NFL provides indust …
  • Black & Veatch Corporation:企業のM&A・提携動向(エネルギー分野)
    Summary Black & Veatch Corporation (Black & Veatch) operates as an engineering, consulting and construction company. It specializes in infrastructure development for diverse markets such as energy, water, telecommunications, federal, and management consulting markets. The company develops customized …
  • Daito Trust Construction Co., Ltd.:企業の戦略・SWOT・財務情報
    Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • City of Hope:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' City of Hope Mergers and Acquis …
  • Anteo Diagnostics Limited (ADO):企業の財務及び戦略的SWOT分析
    Summary Anteo Diagnostics Limited (Anteo) is a medical technology company that provides diagnostic solutions. The company offers developing and commercializing medical and pharmaceutical products. It provides nano-glue technology for life science and in vitro diagnostics, bio-separations, medical de …
  • Albert David Limited (524075):企業概要、財務及び戦略的SWOT分析
    Summary Albert David Limited (Albert David) is a pharmaceutical company. The company develops, manufactures and markets pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs and disposable syringes and needles. It offers products, such as analgesics, anti-inflammatory, ant …
  • Sutor Technology Group Limited:企業の戦略・SWOT・財務分析
    SummarySutor Technology Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compa …
  • Theranyx Sarl:製薬・医療:M&Aディール及び事業提携情報
    Summary Theranyx Sarl is a bio technology company that develops novel therapeutic drugs and solutions to treat cancer. The company’s main line business involved in generation of functional antibodies to target GPCRs and ion channel receptors. Its antibodies named as Therabodies has scope in target v …
  • SFG Australia Limited (SFW):企業概要、財務及び戦略的SWOT分析
    Summary SFG Australia Limited (SFG) is a financial service provider. The company provides services such as strategic financial advice, portfolio construction and management services, finance brokerage, insurance solutions, stockbroking, corporate superannuation, accounting and tax services. SFG prov …
  • Graphite India Limited (GRAPHITE):企業財務及び戦略的SWOT分析
    Summary Graphite India Limited (GIL) is a chemical company that offers graphite electrode products. The company offers products such as graphite electrodes, carbon products, impervious graphite equipment, speciality products, glass reinforced plastic pipes, and others. It manufactures high speed ste …
  • Fujicco Co Ltd:企業の戦略・SWOT・財務情報
    Fujicco Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Fujicco Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Uni-Select Inc.:企業のM&A・事業提携・投資動向
    Uni-Select Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Uni-Select Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • China First Heavy Industries Company Ltd. (601106):企業概要、財務及び戦略的SWOT分析
    Summary China First Heavy Industries Company Ltd. (CFHI), formerly First Heavy Machinery Works, is a manufacturer of heavy machinery products. The company manufactures and distributes energy equipment, industry equipment, environmental protection equipment and equipment fundamental materials. Its en …
  • CGU Insurance Limited:企業の戦略・SWOT・財務分析
    SummaryCGU Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • HumanOptics AG (H9O):企業概要、財務及び戦略的SWOT分析
    Summary HumanOptics AG (HumanOptics) is a medical device company. The company develops, manufactures and sells eye implants. Its products include intraocular lenses, artificial iris, capsular tension rings, corneal implants, viscoelastic solutions, and rinsing solutions. HumanOptics offers solutions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆